Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Study Investigating Efficacy, Safety and Pharmacokinetics of Concizumab Prophylaxis in Children Below 12 Years With Haemophilia A or B With or Without Inhibitors

NCT05135559 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT05135559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05135559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Study Investigating Efficacy, Safety and Pharmacokinetics of Concizumab Prophylaxis in Children Below 12 Years With Haemophilia A or B With or Without Inhibitors
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 24, 2022
Completion date
November 2, 2029
Enrollment
153 (estimated)
Sites
91

Conditions

As the registry lists them; a condition with its own page is linked.

haemophilia a and b with and without inhibitors